Literature DB >> 29781609

Enhancement and Analysis of Human Antiaflatoxin B1 (AFB1) scFv Antibody-Ligand Interaction Using Chain Shuffling.

Kuntalee Rangnoi1, Kiattawee Choowongkomon2, Richard O'Kennedy3, Florian Rüker4, Montarop Yamabhai1.   

Abstract

A human antiaflatoxin B1 (AFB1) scFv antibody (yAFB1-c3), selected from a naı̈ve human phage-displayed scFv library, was used as a template for improving and analysis of antibody-ligand interactions using the chain-shuffling technique. The variable-heavy and variable-light (VH/VL)-shuffled library was constructed from the VH of 25 preselected clones recombined with the VL of yAFB1-c3 and vice versa. Affinity selection from these libraries demonstrated that the VH domain played an important role in the binding of scFv to free AFB1. Therefore, in the next step, VH-shuffled scFv library was constructed from variable-heavy (VH) chain repertoires, amplified from the naı̈ve library, recombined with the variable-light (VL) chain of the clone yAFB1-c3. This library was then used to select a specific scFv antibody against soluble AFB1 by a standard biopanning method. Three clones that showed improved binding properties were isolated. Amino acid sequence analysis indicated that the improved clones have amino acid mutations in framework 1 (FR1) and the complementarity determining region (CDR1) of the VH chain. One clone, designated sAFH-3e3, showed 7.5-fold improvement in sensitivity over the original scFv clone and was selected for molecular binding studies with AFB1. Homology modeling and molecular docking were used to compare the binding of this and the original clones. The results confirmed that VH is more important than VL for AFB1 binding.

Entities:  

Keywords:  aflatoxin; chain shuffling; enzyme-linked immunosorbent assay (ELISA); single-chain fragment variable (scFv)

Mesh:

Substances:

Year:  2018        PMID: 29781609     DOI: 10.1021/acs.jafc.8b01141

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  7 in total

1.  Site-directed mutations of anti-amantadine scFv antibody by molecular dynamics simulation: prediction and validation.

Authors:  Sanlei Xie; Jianyi Wang; Xuezhi Yu; Tao Peng; Kai Yao; Sihan Wang; Demei Liang; Yuebin Ke; Zhanhui Wang; Haiyang Jiang
Journal:  J Mol Model       Date:  2020-02-04       Impact factor: 1.810

2.  Targeting acute myeloid cell surface using a recombinant antibody isolated from whole-cell biopanning of a phage display human scFv antibody library.

Authors:  Thitima Sumphanapai; Kerry Chester; Surasak Sawatnatee; Jenny Yeung; Montarop Yamabhai
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

Review 3.  Recombinant antibodies and their use for food immunoanalysis.

Authors:  Riikka Peltomaa; Rodrigo Barderas; Elena Benito-Peña; María C Moreno-Bondi
Journal:  Anal Bioanal Chem       Date:  2021-08-21       Impact factor: 4.142

4.  Human Hexa-Histidine-Tagged Single-Chain Variable Fragments for Bioimaging of Bacterial Infections.

Authors:  Thae Thae Min; Montarop Yamabhai
Journal:  ACS Omega       Date:  2020-12-22

5.  Camelization of a murine single-domain antibody against aflatoxin B1 and its antigen-binding analysis.

Authors:  Qian Pang; Yanhong Chen; Hina Mukhtar; Jing Xiong; Xiaohong Wang; Ting Xu; Bruce D Hammock; Jia Wang
Journal:  Mycotoxin Res       Date:  2022-01-13       Impact factor: 3.833

6.  Application of Recombinant Human scFv Antibody as a Powerful Tool to Monitor Nitrogen Fixing Biofertilizer in Rice and Legume.

Authors:  K K Khaing; K Rangnoi; H Michlits; N Boonkerd; N Teaumroong; P Tittabutr; M Yamabhai
Journal:  Microbiol Spectr       Date:  2021-12-15

Review 7.  Mimotopes for Mycotoxins Diagnosis Based on Random Peptides or Recombinant Antibodies from Phage Library.

Authors:  Wei Sun; Yan Zhang; Zhigang Ju
Journal:  Molecules       Date:  2021-12-17       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.